We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current NAN market cap is 826.91M. The company's latest EPS is AUD 0.0656 and P/E is 41.62.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 84.35M | 100.06M | 103.24M | 120.78M | 167.31M |
| Operating Income | 13.66M | 12.34M | 9.78M | 1.84M | 17.79M |
| Net Income | 13.6M | 10.14M | 8.58M | 3.74M | 19.88M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 129.52M | 147.07M | 162.3M | 187.67M | 219.92M |
| Total Liabilities | 19.44M | 22.84M | 26.74M | 48.98M | 56.06M |
| Total Equity | 110.08M | 124.23M | 135.57M | 138.69M | 163.86M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | 4.83M | 22.81M | 7.32M | 6.7M | 23.31M |
| Investing | -2.2M | -1.94M | -1.38M | -6.9M | -3.54M |
| Financing | -461k | -1.31M | -1.03M | -1.97M | -2.71M |
| Market Cap | 826.91M |
| Price to Earnings Ratio | 41.62 |
| Price to Sales Ratio | 4.94 |
| Price to Cash Ratio | 7.37 |
| Price to Book Ratio | 5.05 |
| Dividend Yield | - |
| Shares Outstanding | 302.9M |
| Average Volume (1 week) | 911.42k |
| Average Volume (1 Month) | 1.4M |
| 52 Week Change | -47.50% |
| 52 Week High | 5.80 |
| 52 Week Low | 2.59 |
| Spread (Intraday) | 0.02 (0.74%) |
| Company Name | Nanosonics Limited |
| Address |
14 mars road north sydney, new south wales 2066 |
| Website | https://www.nanosonics.com.au |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
